NL-OMON50204已完成不适用
Course and regulators of phosphate metabolism in diabetic ketoacidosis in type 1 diabetes: a prospective study - Phosphate metabolism in DKA (DKA-Pi)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 13
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age 18 to 75 years
- •- T1DM, diagnosed prior to admission (the T1DM diagnosis should be based upon
- •the presence of (i) hyperglycemia (fasting glucose levels >7.0 mmol/L or random
- •glucose levels >11.1 mmol/L), (ii) c-peptide levels of less than 0.2 nmol/L and
- •(iii) presence of auto-immunity (anti-GAD, anti-islet auto-antibodies and/or
- •zinc receptors))
- •- DKA defined as
- •Blood glucose levels >15mmol/L
- •Presence of urine ketones
- •pH levels <7.30 kPa
- •- Dutch writing and speaking proficiency
- •- Ability to provide oral and written informed consent.
- •- Included in Acutelines, where blood sample was drawn upon ED admission
排除标准
- •- Pregnancy (actual or planned)
- •- Known underlying condition in which phosphate metabolism is altered,
- •including hyperparathyroidism, vitamin D deficiency, Fanconi syndrome,
- •chronic diarrhoea, and use of medication with hypophosphatemia as a
- •side-effect, such a
- •pamidronic acid or ferric carboxymaltose
- •- Inability or unwillingness to meet the protocol requirements
- •- Any severe or uncontrolled medical or psychological condition which, in the
- •opinion of the investigator, would compromise the ability to meet protocol
- •requirements
研究者
相似试验
已完成
不适用
utritional Status and dietary Effects on Phosphorous metabolism and clinical Symptoms in HypophosphatasiaE83.3Disorders of phosphorus metabolism and phosphatasesDRKS00015225Klinische StudieneinheitOrthopädische Klinik König-Ludwig-HausLehrstuhl der Universität Würzburg77
进行中（未招募）
不适用
Intensive Phosphate Control in Development of Renal End Points and Mortality in CKD (the IPeR Study)Patients with Chronic Kidney Disease (CKD) not yet on dialysisMedDRA version: 14.1Level: LLTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 100000004857EUCTR2012-004888-41-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
已完成
不适用
the Regulation of Phosphorus Homeostasis by Dietary Phosphorus Intake in Normal MenHealthyNCT03208075Huashan Hospital6
尚未招募
不适用
The pathophysiology of inorganic polyphosphates ininflammatory bowel disease.HEALTHY VOLUNTEERSK50.9K51.9A04.8Crohn disease, unspecifiedUlcerative colitis, unspecifiedOther specified bacterial intestinal infectionsDRKS00023079Medizinische Universität Graz220
招募中
4 期
Effect of Calcium Carbonate for Reduction of Serum Fibroblast Growth Factor 23 (FGF 23) in Chronic Kidney Disease Stage 3Chronic kidney disease stage 3chronic kidney disease stage 3calcium carbonatephosphate binderFibroblast growth factor 23TCTR20150220001Siriraj Research and Development Fund Type 275